Clinical trial · Interventional
Raman Spectroscopic Analysis of Bronchoscopic Biopsy for Diagnosing Lung Cancer
NCT05799027CI-TRIAL-00065317unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to evaluate raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer in visible lesions in the airway. The main question it aims to answer are: the diagnostic efficacy raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer. The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Raman spectrum | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Raman spectrum analysis
- description
- The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
- interventionNames
- Diagnostic Test: Raman spectrum
Primary outcomes (1)
- measure
- To establish the sensitivities and specificities of Raman spectroscopic analysis of bronchoscopic biopsy for lung cancer.
- timeFrame
- 7 days after the biopsy
- description
- The diagnosis would be confirmed according to the pathological results.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who plan to undergo bronchoscopic biopsy or EBUS-TBNA * Visible intratracheal lesions under bronchoscope * Non-visible lesions suspected of lung cancer Exclusion Criteria: * The patient could not tolerate further examination aimed at clarifying the cause of the disease or refused to accept further examination aimed at clarifying the cause of the disease due to poor general condition, serious organ dysfunction, etc * The patient has no definite diagnosis
References
Publications (0)
Data not yet available
No reference posted for this study.